Increased expression of genes linked to FcεRI signaling and to cytokine and chemokine production in Lyn-deficient mast cells

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 7880-7888

  Hernandez Hansen, Valerie ^a,b   Bard, Julie D J ^a   Tarleton, Christy A ^a   Wilder, Julie A ^b   Lowell, Clifford A ^c   Wilson, Bridget S ^a   Oliver, Janet M ^a,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; COLONY STIMULATING FACTOR 1; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; PROTEIN CCL1; PROTEIN CCL5; PROTEIN CCL7; PROTEIN CCL9; PROTEIN KINASE LYN; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC LINKAGE; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEFICIENCY; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

EID: 29144496947     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.7880     Document Type: Article

References (46)

1. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
2. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, T. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
3. Luster, A. C. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 12: 436-445.
4. Williams, C. M., and S. J. Galli. 2000. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J. Allergy Clin. Immunol. 105: 847-859.
5. Kawakami, Y., J. Kitaura, A. B. Satterthwaite, R. M. Kato, K. Asai, S. E. Hartman, M. Maeda-Yamamoto, C. A. Lowell, D. J. Rawlings, O. N. Witte, and T. Kawakami. 2000. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165: 1210-1219.
6. Hernandez-Hansen, V., G. A. Mackay, C. A. Lowell, B. S. Wilson, and J. M. Oliver. 2004. The Src kinase Lyn is a negative regulator of mast cell proliferation. J. Leukocyte Biol. 75: 143-151.
7. Hernandez-Hansen, V., A. J. Smith, Z. Surviladze, A. Chigaev, T. Mazel, J. Kalesnikoff, C. A. Lowell, G. Krystal, L. A. Sklar, B. S. Wilson, and J. M. Oliver. 2004. Dysregulated FcεRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J. Immunol. 173: 100-112.
8. Odom, S., G. Gomez, M. Kovarova, Y. Furumoto, J. J. Ryan, H. V. Wright, C. Gonzales-Espinosa, M. L. Hibbs, K. W. Harder, and J. Rivera. 2004. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J. Exp. Med. 199: 1491-1502.
9. Hibbs, M. L., D. M. Tarlinton, J. Ames, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
10. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in Lyn-deficient mice. Immunity 3: 549-560.
11. Nishizumi, H., K. Horikawa, I. Mlinaric-Rascan, and T. Yamamoto. 1998. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187: 1343-1348.
12. Chan, V. W. F., F. Meng, P. Soriano, A. L. Defranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69-81.
13. Chan, V. W. F., C. A. Lowell, and A. L. Defranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8: 545-553.
14. Liu, F. T., J. W. Bohn, E. L. Ferry, H. Yamamoto, C. A. Molinaro, L. A. Sherman, N. R. Klinman, and D. H. Katz. 1980. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J. Immunol. 24: 2728-2737.
15. Wilder, J. A., G. K. Olson, Y. C. Chang, K. J. Kwon-Chung, and M. F. Lipscomb. 2002. Complementation of a capsule deficient Cryptococcus neoformans with Cap64 restores virulence in a murine lung infection. Am. J. Respir. Cell Mol. Biol. 26: 306-314.
16. Malbec, O., D. C. Fong, M. Turner, L. J. Tybulewicz, J. C. Cambier, W. H. Fridman, and M. Daeron. 1998. FcεRI-associated Lyn-dependent phosphorylation of FcγRIIB during negative regulation of mast cell activation. J. Immunol. 160: 1647-1658.
17. Kepley, C. L., J. C. Cambier, P. A. Morel, D. Lujan, E. Ortega, B. S. Wilson, and J. M. Oliver. 2000. Negative regulation of FcεRI signaling by FcγRII costimulation in human blood basophiis. J. Allergy Clin. Immunol. 106: 337-348.
18. Gould, H. J., B. J. Sutton, A. J. Beavil, R. L. Beavil, N. McCloskey, H. A. Coker, and D. L. Smurthwaite. 2003. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21: 579-628.
19. 2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J. Immunol. 158: 2350-2355.
20. Chen, H., M. Centola, S. F. Altschul, and H. Metzger. 1998. Characterization of gene expression in resting and activated mast cells. J. Exp. Med. 188: 1657-1668.
21. Cho, S. H., S. W. Tam, S. Demissie-Sanders, S. A. Filler, and C. K. Oh. 2000. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J. Immunol. 165: 3154-3161.
22. Kuramasu, A., Y. Kubota, K. Matsumoto, T. Nakajima, X. M. Sun, T. Watanabe, H. Saito, and H. Ohtsu. 2001. Identification of novel mast cell genes by serial analysis of gene expression in cord blood-derived mast cells. FEBS Lett. 498: 37-41.
23. Nakajima, T., K. Matsumoto, H. Suto, K. Tanaka, M. Ebisawa, H. Tomita, K. Yuki, T. Katsunuma, A. Akasawa, R. Hashida, et al. 2001. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 98: 1127-1134.
24. Sayama, K., M. Diehn, K. Matsuda, C. Lunderius, M. Tsai, S.-Y. Tam, D. Botstein, P. O. Brown, and S. J. Galli. 2002. Transcriptional response of human mast cells stimulated via the FcεRI and identification of mast cells as a source of IL-11. BMC Immunol. 3: 1-5.
25. Nakajima, T., N. Inagaki, H. Tanaka, A. Tanaka, M. Yoshikawa, M. Tamari, K. Hasegawa, K. Matsumoto, H. Tachimoto, M. Ebisawa, et al. 2002. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following FcεRI cross-linking: an interspecies comparison. Blood 100: 3861-3868.
26. 2+-ATPase inhibitor DT-BHQ and antigen-stimulated RBL-2H3 mast cells. Inflamm. Res. 51: 611-618.
27. 2+ mobilization responses. Biochem. Biophys. Res. Comm. 235: 812-819.
28. Huber, M., C. D. Helgason, I. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranuiation. Proc. Natl. Acad. Sci. USA 95: 11330-11335.
29. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
30. Grunig, G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263.
31. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103: 779-788.
32. Wynn, T. A. 2003. IL-13 effector functions. Anna. Rev. Immunol. 21: 425-456.
33. Kimata, H., A. Yoshida, C. Ishioka, M. Fujimoto, I. Lindley, and K. Furusho. 1996. RANTES and macrophage inflammatory protein 1α selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J. Exp. Med. 183: 2397-2402.
34. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162: 2477-2487.
35. Price, K. S., D. S. Friend, E. A. Mellor, N. De Jesus, G. F. M. Watts, and J. Boyce. 2003. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interieukin 13. Am. J. Respir. Cell Mol. Biol. 28: 420-427.
36. Kalesnikoff, J., N. Baur, M. Leitges, M. R. Hughes, J. E. Damen, M. Huber, and G. Krystal. 2002. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-κB activity. J. Immunol. 168: 4737-4746.
37. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192: 729-740.
38. Monticelli, S., D. C. Solymar, and A. Rao. 2004. Role of NFAT proteins in IL13 gene transcription in mast cells. J. Biol. Chem. 279: 36210-36218.
39. Choi, O. H., J.-J. Kim, and J.-P. Kinet. 1996. Calcium mobilization via sphingosine kinase in signaling by the FcεRI antigen receptor. Nature 380: 634-636.
40. Prieschl, E. E., R. Csonga, V. Novotny, G. E. Kikuchi, and T. Baumruker. 1999. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after FcεRI triggering. J. Exp. Med. 190: 1-8.
41. 2+ signals triggered by different phospholipids pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277: 17255-17262.
42. Spiegel, S., and S. Milstien. 2003. Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat. Rev. Mol. Cell Biol. 4: 397-407.
43. Ammit, A. J., A. T. Hastie, L. C. Edsall, R. K. Hoffman, Y. Amrani, V. P. Krymskaya, S. A. Kane, S. P. Peters, R. B. Penn. S. Spiegel, and A. Panettieri. Jr. 2001. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15: 1212-1214.
44. Jolly, P., M. Bektas, A. Olivera, C. Gonzales-Espinosa, R. L. Proia, J. Rivera, S. Milstien, and S. Spiegel. 2004. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199: 959-970.
45. Mimics, Z. K., E. Caudell, G. YanHua, K. Kuwahara, N. Sakaguchi, T. Kurosaki, J. Bumside, K. Mimics, and S. J. Corey. 2004. Microarray analysis of Lyn-deficient B cells reveals germinal center-associated nuclear protein and other genes associated with the lymphoid germinal center. J. Immunol. 172: 4133-4141.
46. Beavit, S.-J. E., K. W. Harder, J, M. Kemp, J. Jones, C. Quilici, F. Casagranda, E. Lam, D. Turner, S. Brennan, P. D. Sly, et al. 2005. Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J. Immunol. 175: 1867-1875.